BACKGROUND AND AIMS: Eosinophils are implicated in the pathogenesis of inflammatory bowel disease (IBD). A subset of IBD patients develops blood eosinophilia, and the clinical profile of these patients is undefined. We sought to characterize IBD patients with and without eosinophilia. METHODS: We studied a prospective registry of 1,176 IBD patients followed in a tertiary referral center. Patients who developed eosinophilia at any time were identified by electronic medical record query. We performed a chart review case-control study comparing patients with recurrent eosinophilia versus randomly selected disease-matched patients with no history of eosinophilia. Histological analysis was performed on selected cases and controls. RESULTS: Eosinophilia at any time was more prevalent in ulcerative colitis (UC) patients than Crohn's disease patients (22.2 versus 12.7%), as was recurrent eosinophilia (3.4 versus 0.7%). UC patients with recurrent eosinophilia were predominantly male compared with the control UC population (81.3 versus 46.9%) and had higher rates of colectomy for either medically refractory disease or dysplasia/cancer than control UC patients (56.3 versus 15.6%). Primary sclerosing cholangitis (PSC) occurred in 37.5% of UC patients with recurrent eosinophilia compared with only 3.1% in the UC controls. Histological analysis of random diagnostic samples from UC patients with recurrent eosinophilia demonstrated a normal eosinophil pattern as seen in the control UC population. CONCLUSIONS: Eosinophilia-associated UC is a subgroup of IBD associated with severe colitis and PSC. Further studies are warranted to characterize molecular mechanisms underlying eosinophilia-associated UC and to determine optimal approaches for therapy.
BACKGROUND AND AIMS: Eosinophils are implicated in the pathogenesis of inflammatory bowel disease (IBD). A subset of IBDpatients develops blood eosinophilia, and the clinical profile of these patients is undefined. We sought to characterize IBDpatients with and without eosinophilia. METHODS: We studied a prospective registry of 1,176 IBDpatients followed in a tertiary referral center. Patients who developed eosinophilia at any time were identified by electronic medical record query. We performed a chart review case-control study comparing patients with recurrent eosinophilia versus randomly selected disease-matched patients with no history of eosinophilia. Histological analysis was performed on selected cases and controls. RESULTS:Eosinophilia at any time was more prevalent in ulcerative colitis (UC) patients than Crohn's diseasepatients (22.2 versus 12.7%), as was recurrent eosinophilia (3.4 versus 0.7%). UC patients with recurrent eosinophilia were predominantly male compared with the control UC population (81.3 versus 46.9%) and had higher rates of colectomy for either medically refractory disease or dysplasia/cancer than control UC patients (56.3 versus 15.6%). Primary sclerosing cholangitis (PSC) occurred in 37.5% of UC patients with recurrent eosinophilia compared with only 3.1% in the UC controls. Histological analysis of random diagnostic samples from UC patients with recurrent eosinophilia demonstrated a normal eosinophil pattern as seen in the control UC population. CONCLUSIONS:Eosinophilia-associated UC is a subgroup of IBD associated with severe colitis and PSC. Further studies are warranted to characterize molecular mechanisms underlying eosinophilia-associated UC and to determine optimal approaches for therapy.
Authors: S Delgado; A M Lacy; X Filella; A Castells; J C García-Valdecasas; J M Pique; D Momblán; J Visa Journal: Dis Colon Rectum Date: 2001-05 Impact factor: 4.585
Authors: I Shimomura; Y Takase; S Matsumoto; J Kuyama; T Nakajima; H Maeda; T Sugase; A Hata; M Hanada; M Okuno Journal: J Gastroenterol Date: 1996-10 Impact factor: 7.527
Authors: Samantha A Woodruff; Joanne C Masterson; Sophie Fillon; Zachary D Robinson; Glenn T Furuta Journal: J Pediatr Gastroenterol Nutr Date: 2011-06 Impact factor: 2.839
Authors: Amparo Mir; Miguel Minguez; Jose Tatay; Isabel Pascual; Antonio Peña; Vicente Sanchiz; Pedro Almela; Francisco Mora; Adolfo Benages Journal: Am J Gastroenterol Date: 2002-06 Impact factor: 10.864
Authors: Benjamin Click; Alyce M Anderson; Ioannis E Koutroubakis; Claudia Ramos Rivers; Dmitriy Babichenko; Jorge D Machicado; Douglas J Hartman; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Arthur Barrie; Sally E Wenzel; Miguel Regueiro; David G Binion Journal: Am J Gastroenterol Date: 2017-11-07 Impact factor: 10.864
Authors: Christian Rupp; Konrad Alexander Bode; Fadi Chahoud; Andreas Wannhoff; Kilian Friedrich; Karl-Heinz Weiss; Peter Sauer; Wolfgang Stremmel; Daniel Nils Gotthardt Journal: BMC Infect Dis Date: 2014-10-23 Impact factor: 3.090
Authors: Rhiannon T Filippone; Narges Dargahi; Rajaraman Eri; Jose A Uranga; Joel C Bornstein; Vasso Apostolopoulos; Kulmira Nurgali Journal: Int J Mol Sci Date: 2022-07-14 Impact factor: 6.208
Authors: Lori A Coburn; Sara N Horst; Rupesh Chaturvedi; Caroline T Brown; Margaret M Allaman; Brooks P Scull; Kshipra Singh; M Blanca Piazuelo; Maithili V Chitnavis; Mallary E Hodges; Michael J Rosen; Christopher S Williams; James C Slaughter; Dawn B Beaulieu; David A Schwartz; Keith T Wilson Journal: PLoS One Date: 2013-12-18 Impact factor: 3.240